PMID: 7516743Feb 1, 1994Paper

S-phase determination of immunoselected cytokeratin-containing breast cancer cells improves the prediction of recurrence

Breast Cancer Research and Treatment
S WingrenB Nordenskjöld

Abstract

Estimation of S-phase fraction in breast carcinomas with single parameter flow cytometry may include errors due to dilution of cancer cells by host cells. Use of tissue specific markers may to some extent correct for the effect of dilution. S-phase fraction was estimated by flow cytometry with and without immunoselection in 80 DNA-euploid breast carcinomas in stage I-II. The tumor tissue was mechanically disintegrated and fixed in ethanol. A primary antibody, specific for cytokeratins 8 and 18, was added before incubation with the secondary FITC-conjugated antibody. S-phase fraction was calculated for both the gated (cytokeratin-positive) and the ungated cell population. An increasing proportion of tetraploid cells compared to diploid cells was found when the immunoselection method was used. The gated population tended to have a higher S-phase fraction than the ungated population. In univariate analysis S-phase fraction estimated from both ungated and gated cell populations yielded significant information for predicting recurrence when stratified for tumor size and nodal status. In bivariate analysis S-phase fraction of the gated population contributed prognostic information in addition to S-phase fraction of the ungated popula...Continue Reading

References

Jan 1, 1991·Cytometry·C B BagwellE J Lovett
Nov 1, 1991·British Journal of Cancer·D G Altman
Nov 1, 1988·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·H MygindP P Clausen
Mar 9, 1989·The New England Journal of Medicine·G M ClarkW L McGuire
Sep 1, 1984·Journal of Clinical Pathology·C A MakinW F Bodmer

❮ Previous
Next ❯

Citations

Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S Wingren, O Stål
Oct 1, 1994·International Journal of Cancer. Journal International Du Cancer·S WingrenB Nordenskjöld
Mar 6, 1999·Breast Cancer Research and Treatment·C R Wenger, G M Clark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.